

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 6.80236006 |
| 2 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.61362522 |
| 3 | cytidine catabolic process (GO:0006216) | 5.42713281 |
| 4 | cytidine deamination (GO:0009972) | 5.42713281 |
| 5 | cytidine metabolic process (GO:0046087) | 5.42713281 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.78059619 |
| 7 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.14255305 |
| 8 | metallo-sulfur cluster assembly (GO:0031163) | 3.73411862 |
| 9 | iron-sulfur cluster assembly (GO:0016226) | 3.73411862 |
| 10 | actin nucleation (GO:0045010) | 3.70663446 |
| 11 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.49959092 |
| 12 | proteasome assembly (GO:0043248) | 3.49353589 |
| 13 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.43640405 |
| 14 | sequestering of actin monomers (GO:0042989) | 3.37543661 |
| 15 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.35045734 |
| 16 | ubiquinone biosynthetic process (GO:0006744) | 3.29888499 |
| 17 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.26472266 |
| 18 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.26472266 |
| 19 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.26472266 |
| 20 | negative regulation of T cell apoptotic process (GO:0070233) | 3.23836437 |
| 21 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.23204732 |
| 22 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.23204732 |
| 23 | protein neddylation (GO:0045116) | 3.19146232 |
| 24 | protein deneddylation (GO:0000338) | 3.17764469 |
| 25 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.17616185 |
| 26 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.17616185 |
| 27 | positive regulation of defense response to virus by host (GO:0002230) | 3.17459697 |
| 28 | mannosylation (GO:0097502) | 3.17198460 |
| 29 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.16349544 |
| 30 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.16061384 |
| 31 | positive regulation of prostaglandin secretion (GO:0032308) | 3.11887032 |
| 32 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.11267848 |
| 33 | negative regulation of ligase activity (GO:0051352) | 3.11267848 |
| 34 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.10154592 |
| 35 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.09262304 |
| 36 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.09262304 |
| 37 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.08358754 |
| 38 | ubiquinone metabolic process (GO:0006743) | 3.08211717 |
| 39 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.06449552 |
| 40 | GPI anchor biosynthetic process (GO:0006506) | 3.06363212 |
| 41 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.03224296 |
| 42 | ATP synthesis coupled proton transport (GO:0015986) | 3.03224296 |
| 43 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.00748749 |
| 44 | cellular response to interleukin-15 (GO:0071350) | 3.00186975 |
| 45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.99854590 |
| 46 | base-excision repair, AP site formation (GO:0006285) | 2.99435029 |
| 47 | positive regulation of T cell cytokine production (GO:0002726) | 2.99008122 |
| 48 | GPI anchor metabolic process (GO:0006505) | 2.99001855 |
| 49 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.98114804 |
| 50 | response to interferon-beta (GO:0035456) | 2.97877738 |
| 51 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.94674145 |
| 52 | protein-cofactor linkage (GO:0018065) | 2.92601193 |
| 53 | cullin deneddylation (GO:0010388) | 2.92245861 |
| 54 | adenosine metabolic process (GO:0046085) | 2.92159816 |
| 55 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.90806897 |
| 56 | termination of RNA polymerase III transcription (GO:0006386) | 2.87475747 |
| 57 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.87475747 |
| 58 | negative regulation by host of viral transcription (GO:0043922) | 2.86269629 |
| 59 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.82475010 |
| 60 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.82291315 |
| 61 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.76730391 |
| 62 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.75643144 |
| 63 | regulation of interleukin-8 secretion (GO:2000482) | 2.75607346 |
| 64 | rRNA modification (GO:0000154) | 2.73908781 |
| 65 | positive thymic T cell selection (GO:0045059) | 2.71872315 |
| 66 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.71468548 |
| 67 | protein complex biogenesis (GO:0070271) | 2.71160848 |
| 68 | L-methionine salvage (GO:0071267) | 2.70977999 |
| 69 | L-methionine biosynthetic process (GO:0071265) | 2.70977999 |
| 70 | amino acid salvage (GO:0043102) | 2.70977999 |
| 71 | negative T cell selection (GO:0043383) | 2.70911665 |
| 72 | branched-chain amino acid catabolic process (GO:0009083) | 2.69393685 |
| 73 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.66900159 |
| 74 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.66017658 |
| 75 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.65197006 |
| 76 | regulation of chronic inflammatory response (GO:0002676) | 2.65140940 |
| 77 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.65105174 |
| 78 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.64914673 |
| 79 | positive regulation of T cell mediated immunity (GO:0002711) | 2.62877886 |
| 80 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.62495226 |
| 81 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.62255146 |
| 82 | quinone biosynthetic process (GO:1901663) | 2.58324257 |
| 83 | DNA demethylation (GO:0080111) | 2.57548207 |
| 84 | S-adenosylmethionine metabolic process (GO:0046500) | 2.56647190 |
| 85 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.56315762 |
| 86 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.54957109 |
| 87 | regulation of regulatory T cell differentiation (GO:0045589) | 2.54631203 |
| 88 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.53862460 |
| 89 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.53003232 |
| 90 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.52985246 |
| 91 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.52557693 |
| 92 | NADH dehydrogenase complex assembly (GO:0010257) | 2.52557693 |
| 93 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.52557693 |
| 94 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.51917245 |
| 95 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.51773912 |
| 96 | positive regulation of ligase activity (GO:0051351) | 2.51311186 |
| 97 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.50160319 |
| 98 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.49253908 |
| 99 | regulation of defense response to virus by host (GO:0050691) | 2.48660642 |
| 100 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.48407495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.36913889 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.23748523 |
| 3 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 4.17772372 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.97850668 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.66645127 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.36062829 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.30185402 |
| 8 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.99328366 |
| 9 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.98425590 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.93016724 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.77292692 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.70526143 |
| 13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.60028052 |
| 14 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.44403471 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.39915728 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.35225831 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.35178361 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.34283389 |
| 19 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.27936158 |
| 20 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.26939636 |
| 21 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.24551398 |
| 22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.22236866 |
| 23 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.07160533 |
| 24 | VDR_22108803_ChIP-Seq_LS180_Human | 1.91868184 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.90827627 |
| 26 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.87092230 |
| 27 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.80563279 |
| 28 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.79042869 |
| 29 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.77609286 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 1.75136184 |
| 31 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.70752165 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.69948268 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69641375 |
| 34 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.68853520 |
| 35 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.68841273 |
| 36 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.63989706 |
| 37 | GATA3_26560356_Chip-Seq_TH2_Human | 1.59490746 |
| 38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.59271264 |
| 39 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.57623914 |
| 40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.56433819 |
| 41 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.55103467 |
| 42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.54803492 |
| 43 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.52256868 |
| 44 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51486710 |
| 45 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.47569963 |
| 46 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.47312895 |
| 47 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.47296127 |
| 48 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.43335845 |
| 49 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.43328914 |
| 50 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.41331844 |
| 51 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.37968490 |
| 52 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.34783644 |
| 53 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.33866826 |
| 54 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.30433743 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29215620 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26444903 |
| 57 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.25777064 |
| 58 | AR_20517297_ChIP-Seq_VCAP_Human | 1.24766351 |
| 59 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.24511898 |
| 60 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.22819706 |
| 61 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.22705936 |
| 62 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.22147539 |
| 63 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.20801143 |
| 64 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.20226218 |
| 65 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.17961710 |
| 66 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16248233 |
| 67 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.13351856 |
| 68 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.13351856 |
| 69 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.12893705 |
| 70 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12886883 |
| 71 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12602939 |
| 72 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.12220700 |
| 73 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.12037230 |
| 74 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10449135 |
| 75 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.09739924 |
| 76 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.09568732 |
| 77 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.06755419 |
| 78 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.06145523 |
| 79 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04471406 |
| 80 | EWS_26573619_Chip-Seq_HEK293_Human | 1.03432118 |
| 81 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.03113276 |
| 82 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.01922477 |
| 83 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.98516608 |
| 84 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.98380988 |
| 85 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98067870 |
| 86 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.96395696 |
| 87 | MYB_26560356_Chip-Seq_TH1_Human | 0.95271516 |
| 88 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.95016252 |
| 89 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94095292 |
| 90 | NCOR_22424771_ChIP-Seq_293T_Human | 0.92936582 |
| 91 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.91528417 |
| 92 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.90816072 |
| 93 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.90735449 |
| 94 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.90451258 |
| 95 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.88765151 |
| 96 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.87367347 |
| 97 | FUS_26573619_Chip-Seq_HEK293_Human | 0.86419613 |
| 98 | GATA3_26560356_Chip-Seq_TH1_Human | 0.85973661 |
| 99 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.85528503 |
| 100 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.84739859 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.60780711 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.31286580 |
| 3 | MP0009785_altered_susceptibility_to | 2.77239150 |
| 4 | MP0006072_abnormal_retinal_apoptosis | 2.75618144 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 2.52654489 |
| 6 | MP0002102_abnormal_ear_morphology | 2.35086422 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.34161260 |
| 8 | MP0003724_increased_susceptibility_to | 2.33713126 |
| 9 | MP0000685_abnormal_immune_system | 2.27004302 |
| 10 | MP0004147_increased_porphyrin_level | 2.23648436 |
| 11 | MP0001800_abnormal_humoral_immune | 2.19746637 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.19078213 |
| 13 | MP0000372_irregular_coat_pigmentation | 2.10864941 |
| 14 | MP0002723_abnormal_immune_serum | 2.09624788 |
| 15 | MP0003786_premature_aging | 1.99452388 |
| 16 | MP0005075_abnormal_melanosome_morpholog | 1.95443609 |
| 17 | MP0002420_abnormal_adaptive_immunity | 1.94010321 |
| 18 | MP0001819_abnormal_immune_cell | 1.92023572 |
| 19 | MP0005084_abnormal_gallbladder_morpholo | 1.90927093 |
| 20 | MP0005646_abnormal_pituitary_gland | 1.84090147 |
| 21 | MP0002166_altered_tumor_susceptibility | 1.83074943 |
| 22 | MP0008058_abnormal_DNA_repair | 1.82625470 |
| 23 | MP0002452_abnormal_antigen_presenting | 1.81145965 |
| 24 | MP0009333_abnormal_splenocyte_physiolog | 1.75444945 |
| 25 | MP0005253_abnormal_eye_physiology | 1.74666089 |
| 26 | MP0003806_abnormal_nucleotide_metabolis | 1.74333761 |
| 27 | MP0009764_decreased_sensitivity_to | 1.68210613 |
| 28 | MP0002736_abnormal_nociception_after | 1.67099745 |
| 29 | MP0001790_abnormal_immune_system | 1.66516167 |
| 30 | MP0005387_immune_system_phenotype | 1.66516167 |
| 31 | MP0003436_decreased_susceptibility_to | 1.65846004 |
| 32 | MP0005025_abnormal_response_to | 1.59634967 |
| 33 | MP0002006_tumorigenesis | 1.59224874 |
| 34 | MP0008875_abnormal_xenobiotic_pharmacok | 1.54764722 |
| 35 | MP0002398_abnormal_bone_marrow | 1.51498668 |
| 36 | MP0000716_abnormal_immune_system | 1.49692561 |
| 37 | MP0005645_abnormal_hypothalamus_physiol | 1.48509185 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.47643483 |
| 39 | MP0008872_abnormal_physiological_respon | 1.47299001 |
| 40 | MP0001968_abnormal_touch/_nociception | 1.45863018 |
| 41 | MP0008877_abnormal_DNA_methylation | 1.35213619 |
| 42 | MP0002722_abnormal_immune_system | 1.33503094 |
| 43 | MP0001986_abnormal_taste_sensitivity | 1.32324527 |
| 44 | MP0006082_CNS_inflammation | 1.32057187 |
| 45 | MP0010094_abnormal_chromosome_stability | 1.30477681 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.28522582 |
| 47 | MP0003011_delayed_dark_adaptation | 1.28370101 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.28298847 |
| 49 | MP0001764_abnormal_homeostasis | 1.25618814 |
| 50 | MP0008995_early_reproductive_senescence | 1.24639355 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.23535535 |
| 52 | MP0006035_abnormal_mitochondrial_morpho | 1.22588883 |
| 53 | MP0001905_abnormal_dopamine_level | 1.21918593 |
| 54 | MP0002429_abnormal_blood_cell | 1.21814930 |
| 55 | MP0002419_abnormal_innate_immunity | 1.21531426 |
| 56 | MP0002876_abnormal_thyroid_physiology | 1.20111278 |
| 57 | MP0002405_respiratory_system_inflammati | 1.20070648 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.18864969 |
| 59 | MP0003866_abnormal_defecation | 1.16674272 |
| 60 | MP0008007_abnormal_cellular_replicative | 1.14997997 |
| 61 | MP0006276_abnormal_autonomic_nervous | 1.14030817 |
| 62 | MP0003195_calcinosis | 1.12222526 |
| 63 | MP0005551_abnormal_eye_electrophysiolog | 1.11961600 |
| 64 | MP0009697_abnormal_copulation | 1.11898781 |
| 65 | MP0005410_abnormal_fertilization | 1.11425075 |
| 66 | MP0006036_abnormal_mitochondrial_physio | 1.10345922 |
| 67 | MP0001873_stomach_inflammation | 1.10244078 |
| 68 | MP0001501_abnormal_sleep_pattern | 1.08459274 |
| 69 | MP0003880_abnormal_central_pattern | 1.08175465 |
| 70 | MP0001919_abnormal_reproductive_system | 1.05237831 |
| 71 | MP0002234_abnormal_pharynx_morphology | 1.04598222 |
| 72 | MP0003693_abnormal_embryo_hatching | 1.02518586 |
| 73 | MP0001529_abnormal_vocalization | 1.00066516 |
| 74 | MP0001984_abnormal_olfaction | 0.99928839 |
| 75 | MP0008469_abnormal_protein_level | 0.99510167 |
| 76 | MP0009763_increased_sensitivity_to | 0.99286043 |
| 77 | MP0002933_joint_inflammation | 0.99109964 |
| 78 | MP0006292_abnormal_olfactory_placode | 0.97487705 |
| 79 | MP0002019_abnormal_tumor_incidence | 0.97378466 |
| 80 | MP0005389_reproductive_system_phenotype | 0.91825312 |
| 81 | MP0000465_gastrointestinal_hemorrhage | 0.90657113 |
| 82 | MP0001853_heart_inflammation | 0.90089331 |
| 83 | MP0003718_maternal_effect | 0.88193856 |
| 84 | MP0004145_abnormal_muscle_electrophysio | 0.87559532 |
| 85 | MP0005464_abnormal_platelet_physiology | 0.85777385 |
| 86 | MP0008789_abnormal_olfactory_epithelium | 0.84168364 |
| 87 | MP0004947_skin_inflammation | 0.81273476 |
| 88 | MP0002751_abnormal_autonomic_nervous | 0.80592908 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.79760018 |
| 90 | MP0004142_abnormal_muscle_tone | 0.78168399 |
| 91 | MP0003646_muscle_fatigue | 0.75924992 |
| 92 | MP0001533_abnormal_skeleton_physiology | 0.73957518 |
| 93 | MP0003137_abnormal_impulse_conducting | 0.70160507 |
| 94 | MP0003252_abnormal_bile_duct | 0.69755262 |
| 95 | MP0008873_increased_physiological_sensi | 0.69253027 |
| 96 | MP0004782_abnormal_surfactant_physiolog | 0.68841886 |
| 97 | MP0002277_abnormal_respiratory_mucosa | 0.68703324 |
| 98 | MP0005636_abnormal_mineral_homeostasis | 0.68116198 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.67391514 |
| 100 | MP0001119_abnormal_female_reproductive | 0.65767130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgG deficiency (HP:0004315) | 4.51229900 |
| 2 | Severe combined immunodeficiency (HP:0004430) | 3.60329289 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.60082931 |
| 4 | Mitochondrial inheritance (HP:0001427) | 3.47470069 |
| 5 | Hepatocellular necrosis (HP:0001404) | 3.41109272 |
| 6 | Acute necrotizing encephalopathy (HP:0006965) | 3.33857068 |
| 7 | Abnormality of the prostate (HP:0008775) | 3.31120923 |
| 8 | 3-Methylglutaconic aciduria (HP:0003535) | 3.29270322 |
| 9 | T lymphocytopenia (HP:0005403) | 3.28008509 |
| 10 | Increased CSF lactate (HP:0002490) | 3.25924502 |
| 11 | Abnormality of T cell number (HP:0011839) | 3.23633436 |
| 12 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.11382778 |
| 13 | Hepatic necrosis (HP:0002605) | 3.11320712 |
| 14 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.00165465 |
| 15 | Abolished electroretinogram (ERG) (HP:0000550) | 2.95846150 |
| 16 | Pancreatic cysts (HP:0001737) | 2.91204309 |
| 17 | Acute encephalopathy (HP:0006846) | 2.89673073 |
| 18 | Increased hepatocellular lipid droplets (HP:0006565) | 2.85470036 |
| 19 | Abnormality of eosinophils (HP:0001879) | 2.82422402 |
| 20 | Hypoproteinemia (HP:0003075) | 2.81890184 |
| 21 | Combined immunodeficiency (HP:0005387) | 2.81331046 |
| 22 | IgM deficiency (HP:0002850) | 2.81329404 |
| 23 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.80133228 |
| 24 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.80133228 |
| 25 | Progressive macrocephaly (HP:0004481) | 2.80096201 |
| 26 | Type I transferrin isoform profile (HP:0003642) | 2.79834679 |
| 27 | Increased serum lactate (HP:0002151) | 2.79281375 |
| 28 | Abnormality of T cells (HP:0002843) | 2.79079853 |
| 29 | Increased IgM level (HP:0003496) | 2.69700454 |
| 30 | Methylmalonic acidemia (HP:0002912) | 2.67474509 |
| 31 | Lactic acidosis (HP:0003128) | 2.67181393 |
| 32 | Increased intramyocellular lipid droplets (HP:0012240) | 2.62733962 |
| 33 | Lipid accumulation in hepatocytes (HP:0006561) | 2.56981481 |
| 34 | Thyroiditis (HP:0100646) | 2.56777597 |
| 35 | Attenuation of retinal blood vessels (HP:0007843) | 2.56558789 |
| 36 | Abnormal protein glycosylation (HP:0012346) | 2.55970098 |
| 37 | Abnormal glycosylation (HP:0012345) | 2.55970098 |
| 38 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.55970098 |
| 39 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.55970098 |
| 40 | Cerebral edema (HP:0002181) | 2.54878603 |
| 41 | Aplastic anemia (HP:0001915) | 2.52214453 |
| 42 | Eosinophilia (HP:0001880) | 2.49941607 |
| 43 | Stomatitis (HP:0010280) | 2.48704471 |
| 44 | Abnormality of alanine metabolism (HP:0010916) | 2.46566262 |
| 45 | Hyperalaninemia (HP:0003348) | 2.46566262 |
| 46 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.46566262 |
| 47 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.45199640 |
| 48 | Renal cortical cysts (HP:0000803) | 2.42831939 |
| 49 | Methylmalonic aciduria (HP:0012120) | 2.38407388 |
| 50 | Panhypogammaglobulinemia (HP:0003139) | 2.33026594 |
| 51 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.32487458 |
| 52 | Abnormality of B cell number (HP:0010975) | 2.29781679 |
| 53 | True hermaphroditism (HP:0010459) | 2.29288970 |
| 54 | Autoimmune hemolytic anemia (HP:0001890) | 2.29121322 |
| 55 | Congenital stationary night blindness (HP:0007642) | 2.28710097 |
| 56 | Pancytopenia (HP:0001876) | 2.28540121 |
| 57 | Abnormality of T cell physiology (HP:0011840) | 2.27751028 |
| 58 | Agammaglobulinemia (HP:0004432) | 2.27129825 |
| 59 | Abnormality of midbrain morphology (HP:0002418) | 2.26687764 |
| 60 | Molar tooth sign on MRI (HP:0002419) | 2.26687764 |
| 61 | Renal Fanconi syndrome (HP:0001994) | 2.24349591 |
| 62 | Optic disc pallor (HP:0000543) | 2.21106462 |
| 63 | Encephalitis (HP:0002383) | 2.20363069 |
| 64 | Decreased central vision (HP:0007663) | 2.16521017 |
| 65 | Dicarboxylic aciduria (HP:0003215) | 2.14939968 |
| 66 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.14939968 |
| 67 | Pancreatic fibrosis (HP:0100732) | 2.14863737 |
| 68 | Chronic diarrhea (HP:0002028) | 2.12990906 |
| 69 | Type 2 muscle fiber atrophy (HP:0003554) | 2.08154578 |
| 70 | Amyotrophic lateral sclerosis (HP:0007354) | 2.07772481 |
| 71 | Increased muscle lipid content (HP:0009058) | 2.06467203 |
| 72 | Hypothermia (HP:0002045) | 2.02885442 |
| 73 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.01077866 |
| 74 | Granulocytopenia (HP:0001913) | 2.00455467 |
| 75 | Type II lissencephaly (HP:0007260) | 1.98049956 |
| 76 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.97590953 |
| 77 | Hypoplasia of the uterus (HP:0000013) | 1.95940609 |
| 78 | B lymphocytopenia (HP:0010976) | 1.95618693 |
| 79 | Abnormality of the renal cortex (HP:0011035) | 1.95233978 |
| 80 | Stomach cancer (HP:0012126) | 1.94334647 |
| 81 | Progressive microcephaly (HP:0000253) | 1.93071729 |
| 82 | Delayed CNS myelination (HP:0002188) | 1.92201934 |
| 83 | Lethargy (HP:0001254) | 1.90508597 |
| 84 | Leukocytosis (HP:0001974) | 1.89564613 |
| 85 | Exertional dyspnea (HP:0002875) | 1.89326943 |
| 86 | Nephronophthisis (HP:0000090) | 1.88945872 |
| 87 | Congenital, generalized hypertrichosis (HP:0004540) | 1.88133918 |
| 88 | Ketosis (HP:0001946) | 1.87540830 |
| 89 | Respiratory failure (HP:0002878) | 1.86129810 |
| 90 | Abnormality of male internal genitalia (HP:0000022) | 1.85736679 |
| 91 | Exercise intolerance (HP:0003546) | 1.85614391 |
| 92 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.85272800 |
| 93 | Emotional lability (HP:0000712) | 1.83493676 |
| 94 | Retinal dysplasia (HP:0007973) | 1.82636242 |
| 95 | Recurrent bronchitis (HP:0002837) | 1.82401763 |
| 96 | Abnormality of serum amino acid levels (HP:0003112) | 1.80514200 |
| 97 | Cerebral palsy (HP:0100021) | 1.80319454 |
| 98 | Medial flaring of the eyebrow (HP:0010747) | 1.79311910 |
| 99 | Prostate neoplasm (HP:0100787) | 1.78767263 |
| 100 | Muscle fiber atrophy (HP:0100295) | 1.77940883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 4.43774623 |
| 2 | TXK | 3.86574883 |
| 3 | MAP4K2 | 3.55413952 |
| 4 | TAOK3 | 3.46098980 |
| 5 | BCKDK | 3.24622357 |
| 6 | KDR | 3.09142635 |
| 7 | TLK1 | 2.90873361 |
| 8 | ZAK | 2.82909220 |
| 9 | VRK2 | 2.35112720 |
| 10 | NUAK1 | 2.06411352 |
| 11 | SRPK1 | 2.03141568 |
| 12 | MAP4K1 | 1.83526287 |
| 13 | LIMK1 | 1.76594443 |
| 14 | MAPKAPK3 | 1.75833645 |
| 15 | ADRBK2 | 1.70846687 |
| 16 | EIF2AK3 | 1.66380114 |
| 17 | VRK1 | 1.64152667 |
| 18 | TRIM28 | 1.63482110 |
| 19 | TIE1 | 1.56128704 |
| 20 | BCR | 1.55360122 |
| 21 | ERBB3 | 1.53604591 |
| 22 | TESK1 | 1.52823501 |
| 23 | BUB1 | 1.51563253 |
| 24 | CDK19 | 1.47651908 |
| 25 | GRK1 | 1.47615874 |
| 26 | MAP2K7 | 1.44187019 |
| 27 | ITK | 1.39643106 |
| 28 | CSNK1G3 | 1.33406431 |
| 29 | TEC | 1.30636096 |
| 30 | GRK6 | 1.19314056 |
| 31 | CSF1R | 1.16321413 |
| 32 | DAPK1 | 1.12396202 |
| 33 | FES | 1.07673955 |
| 34 | CSNK1A1L | 1.06581181 |
| 35 | RPS6KA4 | 1.06116180 |
| 36 | STK16 | 1.05001132 |
| 37 | SCYL2 | 1.04418197 |
| 38 | SYK | 1.02921917 |
| 39 | WNK3 | 1.01743069 |
| 40 | IKBKB | 0.99542785 |
| 41 | NEK1 | 0.99421369 |
| 42 | FRK | 0.98546405 |
| 43 | MAP3K4 | 0.97261692 |
| 44 | KIT | 0.96393281 |
| 45 | MST4 | 0.95575021 |
| 46 | TBK1 | 0.94915756 |
| 47 | BMPR1B | 0.94382748 |
| 48 | CSNK1G1 | 0.93153427 |
| 49 | CSNK1G2 | 0.92672082 |
| 50 | RPS6KA5 | 0.89362684 |
| 51 | MAP3K14 | 0.87191486 |
| 52 | OXSR1 | 0.84808843 |
| 53 | IKBKE | 0.83863825 |
| 54 | LCK | 0.80471102 |
| 55 | PINK1 | 0.76977161 |
| 56 | MATK | 0.76957571 |
| 57 | PRKCQ | 0.72606419 |
| 58 | LYN | 0.72263186 |
| 59 | MAP2K2 | 0.71928900 |
| 60 | WNK4 | 0.70882117 |
| 61 | TNK2 | 0.70407611 |
| 62 | PLK4 | 0.69578371 |
| 63 | GRK7 | 0.68416379 |
| 64 | MAPKAPK5 | 0.68060956 |
| 65 | PIM2 | 0.68002484 |
| 66 | CAMKK2 | 0.67715105 |
| 67 | FLT3 | 0.66651751 |
| 68 | BTK | 0.65330391 |
| 69 | TSSK6 | 0.60235144 |
| 70 | MAPK13 | 0.58518508 |
| 71 | EIF2AK2 | 0.57563500 |
| 72 | PLK3 | 0.54674387 |
| 73 | IGF1R | 0.49489479 |
| 74 | SIK3 | 0.49202038 |
| 75 | BMPR2 | 0.48606910 |
| 76 | INSRR | 0.46215441 |
| 77 | MKNK1 | 0.45593114 |
| 78 | ATR | 0.44809224 |
| 79 | MAP2K6 | 0.44770661 |
| 80 | PLK2 | 0.44564815 |
| 81 | JAK3 | 0.43633487 |
| 82 | MAP3K12 | 0.43223762 |
| 83 | ABL1 | 0.42277332 |
| 84 | DYRK2 | 0.41857277 |
| 85 | GRK5 | 0.40062481 |
| 86 | CCNB1 | 0.39631821 |
| 87 | AURKA | 0.39366937 |
| 88 | AURKB | 0.36040157 |
| 89 | PHKG2 | 0.33703277 |
| 90 | PHKG1 | 0.33703277 |
| 91 | ACVR1B | 0.33298449 |
| 92 | ADRBK1 | 0.33245750 |
| 93 | PASK | 0.31712665 |
| 94 | CSNK2A1 | 0.31652055 |
| 95 | PLK1 | 0.31199449 |
| 96 | ZAP70 | 0.29797944 |
| 97 | MUSK | 0.29311644 |
| 98 | CDK8 | 0.27575369 |
| 99 | EGFR | 0.26807579 |
| 100 | PIM1 | 0.25886953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.25712306 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.23665284 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.98101094 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.88497063 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.83729195 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.82367832 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.60563661 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.46832512 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.44069780 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.33988075 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.26012285 |
| 12 | RNA polymerase_Homo sapiens_hsa03020 | 2.25744822 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.03123492 |
| 14 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.02314638 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.73839226 |
| 16 | Protein export_Homo sapiens_hsa03060 | 1.73412035 |
| 17 | Phototransduction_Homo sapiens_hsa04744 | 1.65902758 |
| 18 | Homologous recombination_Homo sapiens_hsa03440 | 1.54414511 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.53456877 |
| 20 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51574613 |
| 21 | DNA replication_Homo sapiens_hsa03030 | 1.49222787 |
| 22 | Mismatch repair_Homo sapiens_hsa03430 | 1.45554324 |
| 23 | Base excision repair_Homo sapiens_hsa03410 | 1.42298675 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.41988478 |
| 25 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.41488744 |
| 26 | Spliceosome_Homo sapiens_hsa03040 | 1.40848286 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.34114799 |
| 28 | RNA degradation_Homo sapiens_hsa03018 | 1.33664852 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.31187761 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.30695746 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.24531747 |
| 32 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.21505629 |
| 33 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.21187600 |
| 34 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.15995689 |
| 35 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.10749953 |
| 36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.10209732 |
| 37 | Alzheimers disease_Homo sapiens_hsa05010 | 1.08352400 |
| 38 | Huntingtons disease_Homo sapiens_hsa05016 | 1.06120632 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.05429191 |
| 40 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.04737262 |
| 41 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.00954479 |
| 42 | Purine metabolism_Homo sapiens_hsa00230 | 1.00338590 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.99164003 |
| 44 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.95681286 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.94836377 |
| 46 | Peroxisome_Homo sapiens_hsa04146 | 0.94735639 |
| 47 | Basal transcription factors_Homo sapiens_hsa03022 | 0.92751553 |
| 48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.91268642 |
| 49 | RNA transport_Homo sapiens_hsa03013 | 0.91071954 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.90518134 |
| 51 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.88447775 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.86815786 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86238401 |
| 54 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.84991509 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.84577193 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.82438409 |
| 57 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.80517243 |
| 58 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.79728468 |
| 59 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.79356269 |
| 60 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.79176562 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76839690 |
| 62 | Ribosome_Homo sapiens_hsa03010 | 0.76357040 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74624851 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.74419097 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 0.72883312 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70656335 |
| 67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.69873377 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.68955820 |
| 69 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.68719076 |
| 70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66361405 |
| 71 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.64506288 |
| 72 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.64159093 |
| 73 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63618133 |
| 74 | Leishmaniasis_Homo sapiens_hsa05140 | 0.62670051 |
| 75 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62150133 |
| 76 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.59256683 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59202941 |
| 78 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.53817083 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49620242 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49276797 |
| 81 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.48953945 |
| 82 | Measles_Homo sapiens_hsa05162 | 0.48739062 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46582543 |
| 84 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46294270 |
| 85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46177605 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44739230 |
| 87 | Legionellosis_Homo sapiens_hsa05134 | 0.44027248 |
| 88 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44016211 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43810310 |
| 90 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42865745 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.40873585 |
| 92 | Olfactory transduction_Homo sapiens_hsa04740 | 0.40829793 |
| 93 | Salmonella infection_Homo sapiens_hsa05132 | 0.40101295 |
| 94 | Carbon metabolism_Homo sapiens_hsa01200 | 0.33137066 |
| 95 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32834468 |
| 96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32287014 |
| 97 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.31330484 |
| 98 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.29601376 |
| 99 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.24713499 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22775318 |

